Article · 4 Mar 2024
Brief reportPublished 25 Jul 2022
Serum Hostile to SPP1 Autoantibody as a Potential Novel Biomarker in Discovery of Esophageal Squamous Cell Carcinoma
Similar by topic
Research article · 2015
Elevated Serum Antibody Levels against Cyclin L2 in Patients with Esophageal Squamous Cell Carcinoma
Conference abstract · 30 Jan 2017
Molecular mechanism investigation of a novel Ruthenium (II) complex inhibits proliferation of human esophageal squamous cell carcinoma
Conference abstract · 12 Mar 2018
Novel autoantibody signatures in plasma exosomes as potential biomarkers for diagnostics and prognosis of non-small-cell lung cancer
Commentary · 21 May 2024
Induced Macrophage M2 Polarization by Tumor-derived Exosomal miR-143-3p Leads to Radiation Resistance in Locally Advanced Esophageal Squamous Cell Carcinoma
More from this journal
The newest in Journal of Cancer Clinical Trials.
Article · 26 Oct 2026
Leveraging Artificial Intelligence to Structure Next-Generation Sequencing Data for Precision Oncology Research: A Real-World Pancreatic Ductal Adenocarcinoma Liquid Biopsy Experience
Article · 3 Jul 2026
The Current Status of Adjuvant Chemotherapy for Colorectal Cancer in Japan: A Paradigm Shift from Oral Fluoropyrimidine Monotherapy to Oxaliplatin-Based Regimens
Brief report · 29 Dec 2025
Validating Cancer Biomarkers: Challenges and Precision Medicine
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Cancer Clinical Trials
- SubjectOncology & Cancer
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Massimo Libra”

